SGHT icon

Sight Sciences

3.84 USD
+0.10
2.67%
At close Updated Mar 17, 12:03 PM EDT
1 day
2.67%
5 days
-2.54%
1 month
-28.22%
3 months
-52.88%
6 months
12.28%
Year to date
-48.66%
1 year
38.13%
5 years
-88.54%
10 years
-88.54%
 

About: Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

Employees: 186

0
Funds holding %
of 8,083 funds
0
Analysts bullish %
of 4 analysts
0
Positive news %
of 7 articles
Price charts implemented using Lightweight Charts™